Genetic Tech Spn ADR (GENE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 12-2021 | 06-2021 | 12-2020 | 06-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,937 | 91 | 12 | 7 | 0 |
| Other Operating Activity | -4,939 | -4,795 | -2,759 | -3,843 | -1,956 |
| Operating Cash Flow | $-3,002 | $-4,704 | $-2,747 | $-3,836 | $-1,956 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -35 | -559 | -403 | -1 | 24 |
| Net Acquisitions | -2,475 | 0 | N/A | 0 | N/A |
| Other Investing Activity | 10 | 0 | 22 | 44 | 30 |
| Investing Cash Flow | $-2,500 | $-559 | $-381 | $44 | $53 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | -23 | 10,229 | 4,736 | 12,329 | 2,769 |
| Financing Cash Flow | $-23 | $10,229 | $4,736 | $12,329 | $2,769 |
| Exchange Rate Effect | 138 | 32 | 16 | -423 | -83 |
| Beginning Cash Position | 15,227 | 10,621 | 10,398 | 1,431 | 1,458 |
| End Cash Position | 9,840 | 15,618 | 12,022 | 9,545 | 2,242 |
| Net Cash Flow | $-5,387 | $4,997 | $1,625 | $8,113 | $783 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,002 | -4,704 | -2,747 | -3,836 | -1,956 |
| Free Cash Flow | -3,002 | -4,704 | -2,747 | -3,836 | -1,956 |